TNF and cancer: As reported, M1 macrophages hinder cancer progression via producing pro-inflammatory mediators (tumor necrosis factor-alpha and interleukin-1), while M2 macrophages advance cancer progression by means of anti-inflammatory cytokine secretion (chemokine 17, chemokine 22, and interleukin-10) [53–57].